Cancer in individuals with obesity and metabolic disorders. A preventable epidemic?

References

[1] Centers for Disease Control and Prevention (U.S.). MMWR. Morbidity and mortality weekly report, Vol. 66, no. 50, December 22, 2017. Available from: https://stacks.cdc.gov/view/cdc/50243 [Last accessed on 25 Nov 2022]

[2] CDC. Adult obesity facts. Available from: https://www.cdc.gov/obesity/data/adult.html [Last accessed on 25 Nov 2022]

[3] Wang YC,Marsh T,Brown M.Health and economic burden of the projected obesity trends in the USA and the UK.Lancet2011;378:815-25

[4] Ng M,Robinson M.Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the global burden of disease study 2013.Lancet2014;384:766-81 PMCID:PMC4624264

[5] Zhou B,Hajifathalian K.Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants.Lancet2016;387:1513-30 PMCID:PMC5081106

[6] Centers for Disease Control and Prevention(CDC). National and state diabetes trends, 2021. Available from: https://www.cdc.gov/diabetes/library/reports/reportcard/national-state-diabetes-trends.html [Last accessed on 25 Nov 2022]

[7] Calle EE,Walker-Thurmond K.Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.N Engl J Med2003;348:1625-38

[8] Scully T,LeRoith D.Obesity, type 2 diabetes, and cancer risk.Front Oncol2020;10:615375 PMCID:PMC7884814

[9] Lonardo F.Metabolism and cancer-select topics.Metab Target Organ Damage2022;2:8

[10] Lonardo A.The “obese liver” and gastrointestinal cancer risk.Transl Gastroenterol Hepatol2020;5:44 PMCID:PMC7063505

[11] Allen AM,Mara KC,Therneau TM.The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - a longitudinal cohort study.J Hepatol2019;71:1229-36 PMCID:PMC6921701

[12] Mauvais-jarvis F,Barnes PJ.Sex and gender: modifiers of health, disease, and medicine.Lancet2020;396:565-82 PMCID:PMC7440877

[13] Simon TG,Khalili H,Ludvigsson JF.Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort.Gut2021;70:1375-82 PMCID:PMC8185553

[14] Lorenzo A, Romano L, Di Renzo L, Di Lorenzo N, Cenname G, Gualtieri P. Obesity: a preventable, treatable, but relapsing disease.Nutrition2020;71:110615

[15] Yu SJ,Kim D et al.Visceral obesity predicts significant fibrosis in patients with NAFLD.Medicine2015;94:e2159

[16] Shi YX,Qiu HN.Visceral fat area to appendicular muscle mass ratio as a predictor for nonalcoholic fatty liver disease independent of obesity.Scand J Gastroenterol2021;56:312-20

[17] Marchesini G,Cortez-Pinto H.Adipose tissue-associated cancer risk: is it the fat around the liver, or the fat inside the liver?.J Hepatol2019;71:1073-5

[18] Lind L,Risérus U.The plasma metabolomic profile is differently associated with liver fat, visceral adipose tissue, and pancreatic fat.J Clin Endocrinol Metab2021;106:e118-29 PMCID:PMC7765636

[19] Rao S,Ohshiro K.β2-spectrin (SPTBN1) as a therapeutic target for diet-induced liver disease and preventing cancer development.Sci Transl Med2021;13:eabk2267 PMCID:PMC8941321

[20] Tumminia A,Parisi M.Adipose tissue, obesity and adiponectin: role in endocrine cancer risk.Int J Mol Sci2019;20:2863 PMCID:PMC6628240

[21] Yanai H.Beneficial effects of adiponectin on glucose and lipid metabolism and atherosclerotic progression: mechanisms and perspectives.Int J Mol Sci2019;20:1190 PMCID:PMC6429491

[22] Rojas E,Bolli P et al.The role of adiponectin in endothelial dysfunction and hypertension.Curr Hypertens Rep2014;16:463

[23] 2019 Cancer Risk Factors Collaborators. The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the global burden of disease study 2019.Lancet2022;400:569-91

[24] Aminian A,Al-Kurd A.Association of bariatric surgery with cancer risk and mortality in adults with obesity.JAMA2022;327:2423-33 PMCID:PMC9166218

[25] Sjöström L,Sjöström CD.Swedish obese subjects studyEffects of bariatric surgery on mortality in Swedish obese subjects.N Engl J Med2007;357:741-52

[26] Safaei M,Driss M,Shapi'i A.A systematic literature review on obesity: understanding the causes & consequences of obesity and reviewing various machine learning approaches used to predict obesity.Comput Biol Med2021;136:104754

[27] Müller MJ,Asbeck I,Grund A.Prevention of obesity-is it possible?.Obes Rev2001;2:15-28

[28] Centers for Disease Control and Prevention(CDC). Proven strategies. Available from: https://www.cdc.gov/nccdphp/dnpao/proven-strategies.html [Last accessed on 25 Nov 2022]

[29] Palacios C,Arrieta A,Tapia R.Obesity in Latin America, a scoping review of public health prevention strategies and an overview of their impact on obesity prevention.Public Health Nutr2021;24:5142-55

[30] Caballero B.Humans agains obesity: who will win?.Adv Nutr2019;10:S4-9

[31] Cole HM.The war against tobacco: 50 years and counting.JAMA2014;311:131-2 PMCID:PMC4465196

[32] Yi C,Wan M,Cheng X.Statins intake and risk of liver cancer: a dose-response meta analysis of prospective cohort studies.Medicine2017;96:e7435 PMCID:PMC5502182

[33] Jeong GH,Kim JY.Statin and cancer mortality and survival: an umbrella systematic review and meta-analysis.J Clin Med2020;9:326 PMCID:PMC7074262